Effect of drug resistance on negative conversion of sputum culture in patients with pulmonary tuberculosis

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Objective: Negative conversion of sputum culture is a useful marker for predicting treatment outcome and relapse of pulmonary tuberculosis (TB). The effect of drug resistance on negative conversion of sputum culture with treatment was evaluated in this study. Methods: A total of 535 patients with culture-proven pulmonary TB were classified into three groups: drug-susceptible (DS), other drug-resistant (ODR), and multidrug-resistant/extensively drug-resistant (MDR/XDR). Rates of conversion of sputum culture at 4, 8, and 12 weeks were compared. Results: At 4 weeks of treatment, the conversion rate in the DS group (52.7%) was higher than that in the ODR group (30.8%, p = 0.003), but was not different compared with the MDR group (45.7%, p = 0.427). At 8 weeks, the conversion rate in the DS group (76.3%) was higher than that in the ODR (63.5%, p = 0.042) and MDR groups (60.0%, p = 0.031). At 12 weeks, the conversion rate in the DS group (85.9%) tended to be higher than that in the MDR group (74.3%, p = 0.062), but was not different from that in the ODR group (84.6%, p = 0.796). Conclusion: The pattern of resistance to anti-TB drugs affects culture conversion rates in the early phase of treatment and also prolongs the time to culture conversion.

Cite

CITATION STYLE

APA

Kim, J., Kwak, N., Lee, H. Y., Kim, T. S., Kim, C. K., Han, S. K., & Yim, J. J. (2016). Effect of drug resistance on negative conversion of sputum culture in patients with pulmonary tuberculosis. International Journal of Infectious Diseases, 42, 64–68. https://doi.org/10.1016/j.ijid.2015.11.018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free